Glen Ibbott - Aurora Cannabis Chief Financial Officer

ACB Stock  CAD 6.50  0.11  1.72%   

CFO

Mr. Glen Ibbott is a Chief Financial Officer of the Company. He is a seasoned senior health care executive with over 20 years of experience providing financial leadership to various public entities, including management of Canadian and international capital market strategies, mergers and acquisitions, and tax and finance, predominantly within the life sciences sector. An innovative, decisive and insightful professional, he has excelled in delivering revenue and profitability growth, both domestically and internationally, strategy execution and shareholder value creation, including key contributions to numerous corporate transactions. Most recently, Mr. Ibbott was CFO at QLT Inc, a Nasdaq Stock Market and Toronto Stock Exchangelisted biopharmaceutical company, and played a key role in QLT 500million merger with Aegerion Pharmaceuticals to form Novelion Therapeutics. Prior to his time at QLT, Mr. Ibbott held various senior finance positions, including with globally operating companies such as Nordion, International Forest Products, Angiotech Pharmaceuticals, Aspreva Pharmaceuticals and Inex Pharmaceuticals. Earlier in his career, he worked within the technology practice of KPMG since 2017.
Tenure 7 years
Professional MarksCPA
Address 90B Street SW, Edmonton, AB, Canada, T6X 1V8
Phone855 279 4652
Webhttps://www.auroramj.com
Ibbott completed MBAs at Cornell University and at Queen University, is a Canadian chartered professional accountant, as well as a U.S. CPA, and holds a bachelor of business administration from Simon Fraser University.

Aurora Cannabis Management Efficiency

The company has return on total asset (ROA) of (0.0124) % which means that it has lost $0.0124 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0579) %, meaning that it generated substantial loss on money invested by shareholders. Aurora Cannabis' management efficiency ratios could be used to measure how well Aurora Cannabis manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -0.1. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Aurora Cannabis' Total Assets are very stable compared to the past year. As of the 3rd of December 2024, Non Current Assets Total is likely to grow to about 744.6 M, while Total Current Assets are likely to drop about 234.2 M.
Aurora Cannabis has accumulated 104.79 M in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. Aurora Cannabis has a current ratio of 5.03, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aurora Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, Aurora Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurora Cannabis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurora to invest in growth at high rates of return. When we think about Aurora Cannabis' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CFO Age

CFA CAWheaton Precious Metals
57
Sean WashchukCCL Industries
51
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. AURORA CANNABIS is traded on Toronto Stock Exchange in Canada. Aurora Cannabis (ACB) is traded on Toronto Exchange in Canada and employs 1,073 people. Aurora Cannabis is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Aurora Cannabis Leadership Team

Elected by the shareholders, the Aurora Cannabis' board of directors comprises two types of representatives: Aurora Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurora. The board's role is to monitor Aurora Cannabis' management team and ensure that shareholders' interests are well served. Aurora Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurora Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
Lori Schick, Executive Resources
Simona King, Chief Officer
Alex Miller, Executive Chain
Darren Karasiuk, Executive Vice President - Adult Usage
Carey Squires, Executive Vice President of Corporate Development and Strategy
Jillian Swainson, Chief Legal Officer, Corporate Secretary
Michael Singer, Executive Chairman of the Board, Interim Chief Executive Officer
Andre Jerome, Senior Vice President - Business Integration
Dave Aird, Executive Technology
Miguel Martin, Chief Commercial Officer
Nathalie Clark, General VP
Steve Dobler, President Director
Adam Szweras, Independent Director
Jonathan Page, Chief Science Officer
Neil Belot, Chief Global Business Development Officer
Debra Wilson, Vice President of Human Resources
Ananth Krishnan, Vice Relations
Lance Friedmann, Independent Director
David Aird, Executive Technology
John Barnet, Chief Cultivator
Margaret Atkins, Independent Director
Glen Ibbott, Chief Financial Officer
Michael Detlefsen, Independent Director
Simona CPA, Chief Officer
Darryl Vleeming, Chief Information Officer
Thomas Larssen, President of Aurora Larssen Projects Ltd
Rick Savone, Senior Vice President - Global Government Relations
Norma Beauchamp, Independent Director
Ronald Funk, Lead Independent Director
Michelle Lefler, Vice Relations
Allan Cleiren, Chief Operational Officer
Jason Dyck, Independent Director

Aurora Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aurora Cannabis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Aurora Cannabis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aurora Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Cannabis will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aurora Stock

  0.69CMC Cielo Waste SolutionsPairCorr

Moving against Aurora Stock

  0.58LQWD LQwD FinTech CorpPairCorr
The ability to find closely correlated positions to Aurora Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aurora Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aurora Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aurora Cannabis to buy it.
The correlation of Aurora Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aurora Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aurora Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aurora Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Aurora Stock, please use our How to Invest in Aurora Cannabis guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.